Lipocine Inc. (LPCN)
NASDAQ: LPCN · IEX Real-Time Price · USD
7.56
-0.16 (-2.07%)
At close: Jul 2, 2024, 4:00 PM
7.93
+0.37 (4.89%)
After-hours: Jul 2, 2024, 6:19 PM EDT
Lipocine Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lipocine stock has a target of 33, which predicts an increase of 336.51% from the current stock price of 7.56.
Analyst Consensus: Buy
* Price targets were last updated on Jul 27, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for Lipocine is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '23 | Mar '23 | Apr '23 | May '23 | Jun '23 | Jul '23 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $33 | Buy | Reiterates | $33 | +336.51% | Jul 27, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Aug 26, 2021 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 24, 2021 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | May 27, 2021 |
Ladenburg Thalmann | Ladenburg Thalmann | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Dec 10, 2020 |
Financial Forecast
Revenue This Year
9.13M
from -2.85M
Revenue Next Year
16.58M
from 9.13M
Increased by 81.58%
EPS This Year
-1.02
from -3.14
EPS Next Year
-0.06
from -1.02
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 9.4M | 17.1M | 33.1M | 27.8M | 53.8M |
Avg | 9.1M | 16.6M | 32.1M | 27.0M | 52.2M |
Low | 8.8M | 15.9M | 30.9M | 26.0M | 50.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | 86.9% | 99.6% | -13.4% | 98.9% |
Avg | - | 81.6% | 93.9% | -15.9% | 93.2% |
Low | - | 74.5% | 86.3% | -19.2% | 85.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.05 | -0.06 | 0.97 |
Avg | -1.02 | -0.06 | 0.94 |
Low | -0.98 | -0.06 | 0.90 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.